Notably, APC‐derived mutations were predominantly observed in colorectal cancer (18.6%, 11/59), while TERT promoter and CTNNB1 mutations were most found in liver cancer, with detection rates of 34.5% (10/29) and 24.1% (7/29), respectively. This evidence concerns the gene TERT and liver cancer.